How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.

导出 OA

翻译打印收藏纠错

第一作者： Tanmay,Sharma

第一单位： Medical Student, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

作者： Tanmay,Sharma ^[1] ; Intisar,Qamar ^[1] ; Merrick,Zwarenstein ^[2]

作者单位： Medical Student, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. ^[1] Departments of Epidemiology & Biostatistics, and Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada N6A 5C1. Electronic address: merrick.zwarenstein@ices.on.ca. ^[2]

关键词 COVID-19 Favipiravir Methodological review PRECIS-2 Pragmatic trials Remdesivir

主题词人类(Humans);医院(Hospitals);随机对照试验(主题)(Randomized Controlled Trials as Topic);研究设计(Research Design)

DOI 10.1016/j.jclinepi.2022.10.013

PMID 36265553

发布时间 2023-02-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交